Empowering women with better ways to understand, monitor and improve their menstrual, hormonal and reproductive health
Daye has raised €12M across 1 funding round from 3 investors, most recently a Series A round in Oct 2022. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-26 | Series A | €12M |
| Cross Border Impact Ventures,Hambro Perks,MassMutual Ventures (MMV) |
| View deal → |
